Rainier Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.16M Sell
23,720
-7,170
-23% -$596K 0.91% 60
2017
Q3
$2.35M Sell
30,890
-12,040
-28% -$910K 0.55% 85
2017
Q2
$3.22M Sell
42,930
-63,290
-60% -$4.39M 0.64% 68
2017
Q1
$6.93M Sell
106,220
-13,180
-11% -$776K 0.75% 58
2016
Q4
$6.58M Buy
119,400
+10,100
+9% +$554K 0.64% 64
2016
Q3
$6.18M Buy
+109,300
New +$5.36M 0.4% 111

Other funds holding PRAH

Rainier Investment Management's PRAH Position: Q4 2017 in Review

Rainier Investment Management reduced its PRA Health Sciences, Inc. (PRAH) stake by 23% in Q4 2017, selling an estimated $596K and leaving 23,720 shares worth $2.16M. The position accounts for 0.91% of the portfolio, ranked #60.

Rainier Investment Management first reported a position in PRAH in Q3 2016 and has held it in 6 quarters since. The position peaked at $6.93M in Q1 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Rainier Investment Management held 23,720 shares of PRA Health Sciences, Inc. worth $2.16M as of Q4 2017.
  • Rainier Investment Management sold 7,170 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $596K.
  • PRA Health Sciences, Inc. made up 0.91% of Rainier Investment Management's portfolio in Q4 2017, its #60 holding.
  • Rainier Investment Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and has held it in 6 quarters since.
  • Rainier Investment Management's PRA Health Sciences, Inc. position peaked at $6.93M in Q1 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Rainier Investment Management's 13F filing for Q4 2017, filed 2 Feb 2018.